Journal
Neuro-Oncology Advances
Publication Date
1-1-2025
Volume
7
Issue
1
First Page
vdaf215
Document Type
Open Access Publication
DOI
10.1093/noajnl/vdaf215
Rights and Permissions
Talia Eligator, Jit Chatterjee, Shintaro Yamada, Anthony Kirchner, Hareesh B Nair, Jason R Fangusaro, David H Gutmann, Head-to-head preclinical treatment design prioritizes promising therapies for neurofibromatosis type 1 optic glioma clinical translation, Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf215, https://doi.org/10.1093/noajnl/vdaf215. https://academic.oup.com/noa/article/7/1/vdaf215/8272888?login=true. © The Author(s) 2025. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Eligator, Talia; Chatterjee, Jit; Yamada, Shintaro; Kirchner, Anthony; Nair, Hareesh B; Fangusaro, Jason R; and Gutmann, David H, "Head-to-head preclinical treatment design prioritizes promising therapies for neurofibromatosis type 1 optic glioma clinical translation." Neuro-Oncology Advances. 7, 1. vdaf215 (2025).
https://digitalcommons.wustl.edu/oa_4/5999
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
